Recent

% | $
Quotes you view appear here for quick access.

Inovio Pharmaceuticals, Inc. Message Board

  • atlman79 atlman79 Jul 18, 2013 9:08 AM Flag

    At bottom of all new press releases I love seeing this..........

    INO Partners and collaborators include the University of Pennsylvania, Merck, National Cancer Institute, U.S. Military HIV Research Program, NIH, HIV Vaccines Trial Network, University of Southampton, US Dept. of Homeland Security, University of Manitoba and PATH Malaria Vaccine Initiative.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • That is because the synthesis of recombinant molecules, proteonomic molecules, or purification of molecules that are used in these vaccines is a $ multi-million task in itself. The basis for molecular manipulations is all predicated on finding a safe, effective molecule or anti-molecule. Inovio provides the method for getting the treatment preparation in the optimum spot. That service business is a 20% profit per year business using other institutions molecules. If they make a breakthrough molecule themselves that is proprietary to Inovio, then they get the big profits. Usually the mark-up is several 100% for a proprietary product that is patented and market protected like an orphan application.

      Sentiment: Strong Buy

    • Nice seeing all the big guys are supporting INO.

      Sentiment: Strong Buy

    • Some serious partners there!!

 
INO
8.42+0.260(+3.19%)May 1 4:00 PMEDT